Melanoma survival double with both immunotherapy AND local peripheral treatments.

Sciencedaily.com today reported a study and clinical trial which showed that metastatic melanoma patients who received BOTH ipilimumab/Yervoy AND local peripheral treatments had more than double the survival period (93 weeks) of those who only received Yerboy (42 weeks).

This is an especially interesting subject to me because I'm a malignant melanoma survivor from a decade ago and I wrote a booklet about how I survived before these treatments were available,
http://www.amazon.com/John-A.-McCormick/e/B00287RNFS

Back a decade ago there were NO chemotherapy treatments for malignant melanoma which did more than make a very marginal improvement in life expectancy.

I found European clinical studies which showed that Vitamin D-3 more than doubled the survival rate.

There is also considerable evidence that the spice turmeric - often found in curry, also improves your chances of survival.

Since neither of these would in any way interfere with more recent treatments I suggest patients read the scientific results I cite in my book and consider adding Vitamin D-3 and or turmeric to their diets.

My book is the lowest price I could set, 99-cents and Amazon Prime members can read it for free.

Linus Pauling Vindicated on Vitamin C??Cancer Study Says YES!

Since I only post critical news, rather than attempt a story every day, you might want to subscribe for a feed so you don't miss anything that might save your life. The only limit on postings is that they must be critical news with life-saving potential.

Two time Nobel Laureate Linus Pauling was ridiculed for his suggestion that high dose Vitamin C could fight cancers but recent studies show he may have been on track for a third Nobel for his suggestion.

For ovarian cancer there is an open text study published at www.ncbi.nlm.nih.gov

Two key paragraphs are these found near the end.

“For patients, quality of life is a key issue. In a self-assessment administered to 39 terminal cancer patients treated with 10 g of intravenous ascorbate at 3 day intervals combined with daily administration of 4 g orally for 1 week, quality of life was reportedly improved on several scales. Specifically, patients rated physical, emotional, and cognitive function higher and several symptoms, including nausea, vomiting, loss of appetite, and fatigue, lower after ascorbate treatment. Similarly, advanced cancer patients in the phase I trial who received intravenous ascorbate doses >0.4 g/kg sustained quality of life for the duration of the trial.”

However, neither of these trials had a placebo control. How intravenous ascorbate might mediate improved wellbeing is unknown; further examination with appropriate placebo controls may be worthwhile.

In summary, intravenous ascorbate therapy is safe, well tolerated, and has minimal side effects compared to most standard agents, as verified by both case studies and early clinical trials. Additionally, intravenous ascorbate may contribute to maintaining quality of life.

“Current trials are investigating the potential efficacy of pharmacologic ascorbate given over longer durations in combination with standard chemotherapies.”

Very recent studies just published in Science, the journal of the American Association for the Advancement of Science into the use of Vitamin C in treating two kinds of cancer in rats show very promising results and the same cancer types are found in difficult-to-treat human cancers.

Although the actual study is available only to members, the AAAS provides a summary atsciencemag.org

This study found that colon cancer cells often grow because of mutations in the KRAS or BRAF genes. These cells are fed by high levels of glucose (sugar) but the transporter, GLUT1 also carries Vitamin C to cells as the dehydroascorbic acid (DHA) oxidized form.

Bombarding the cells with high doses of the DHA (Vitamin C) can block free radicals and high doses actually do kill those colon cancers in the lab. The dosages required would require patients eating unbelievable amounts of fruits such as oranges but fortunately the same Vitamin C can be purchased in kilogram packages very inexpensively and mixed with sterile water for IV feeds.

Conclusions?

Since Vitamin C is very cheap and people can not only tolerate it in massive dosages but will probably actually improve their quality of life, it appears that human trials could easily be approved and conducted. Because there is no real safety question, some doctors may agree to give their cancer patients the massive doses along with whatever traditional treatment such as chemotherapy which they are already getting.

I wrote this up before beginning this blog at 

http://newsblaze.com/issues/science/linus-pauling-vitamin-c-theory-vindicated_40227/